These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24069035)

  • 1. The role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk.
    Ellington DR; Richter HE
    Obstet Gynecol Int; 2013; 2013():356960. PubMed ID: 24069035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in utilization of transvaginal mesh.
    Kohli N
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):337-42. PubMed ID: 22954765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enmeshed in Controversy: Use of Vaginal Mesh in the Current Medicolegal Environment.
    Kuhlmann-Capek MJ; Kilic GS; Shah AB; Diken ZM; Snyder RR; Phelps JY
    Female Pelvic Med Reconstr Surg; 2015; 21(5):241-3. PubMed ID: 26313491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons Learned from the MAUDE Database on Transvaginal Synthetic Mesh and Sling Reports.
    Abraham A; Tzartzeva K; Christie A; Zimmern P
    Urol Pract; 2017 Mar; 4(2):111-117. PubMed ID: 37592616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the 2011 Notification on Serious Complications Associated with Transvaginal Mesh.
    Drain A; Khan A; Ohmann EL; Brucker BM; Smilen S; Rosenblum N; Nitti VW
    J Urol; 2017 Apr; 197(4):1092-1098. PubMed ID: 27866958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Techniques of transvaginal mesh prolapse surgery in Japan, and the comparison of complication rates by surgeons' specialty and experience.
    Kato K; Gotoh M; Takahashi S; Kusanishi H; Takeyama M; Koyama M
    Int J Urol; 2020 Nov; 27(11):996-1000. PubMed ID: 32776359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufacturer and User Facility Device Experience Reporting of Events Related to Transvaginal Mesh: Understanding the Data.
    Dallas K; Souders CP; Caron A; Clark K; Obi N; McClelland L; Chughtai B; Eilber KS; Anger JT
    Female Pelvic Med Reconstr Surg; 2022 May; 28(5):332-335. PubMed ID: 35421039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh.
    Sandberg JM; Gray I; Pearlman A; Terlecki RP
    Investig Clin Urol; 2018 Mar; 59(2):126-132. PubMed ID: 29520389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update.
    Koo K; Gormley EA
    Neurourol Urodyn; 2017 Feb; 36(2):329-332. PubMed ID: 26575470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Committee Opinion no. 513: vaginal placement of synthetic mesh for pelvic organ prolapse.
    Obstet Gynecol; 2011 Dec; 118(6):1459-1464. PubMed ID: 22105294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transvaginal mesh procedures for pelvic organ prolapse.
    Walter JE;
    J Obstet Gynaecol Can; 2011 Feb; 33(2):168-174. PubMed ID: 21352637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal placement of synthetic mesh for pelvic organ prolapse.
    Committee on Gynecologic Practice
    Female Pelvic Med Reconstr Surg; 2012; 18(1):5-9. PubMed ID: 22453257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Media coverage of the 2019 United States Food and Drug Administration ordered withdrawal of vaginal mesh products for pelvic organ prolapse.
    Shoureshi PS; Lee W; Kobashi KC; Sajadi KP
    Int Urogynecol J; 2021 Feb; 32(2):375-379. PubMed ID: 32601782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of pelvic organ prolapse in women.
    Maher C; Feiner B; Baessler K; Schmid C
    Cochrane Database Syst Rev; 2013 Apr; (4):CD004014. PubMed ID: 23633316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvaginal polytetrafluoroethylene mesh surgery for pelvic organ prolapse: 1-year clinical outcomes.
    Kawaguchi S; Narimoto K; Hamuro A; Nakagawa T; Urata S; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Nohara T; Shigehara K; Izumi K; Tachibana D; Kadono Y; Mizokami A; Koyama M
    Int J Urol; 2021 Mar; 28(3):268-272. PubMed ID: 33760315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New considerations in the use of vaginal mesh for prolapse repair.
    Rardin CR; Washington BB
    J Minim Invasive Gynecol; 2009; 16(3):360-4. PubMed ID: 19423069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historic transvaginal meshes and procedures: what did my patient have done?
    Jacobs KM; Sammarco AG; Madsen AM
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):477-484. PubMed ID: 31693569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic mesh complications in women before and after the 2011 FDA public health notification.
    Rice NT; Hu Y; Slaughter JC; Ward RM
    Female Pelvic Med Reconstr Surg; 2013; 19(6):333-8. PubMed ID: 24165446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvaginal mesh for prolapse repair: what is all the controversy about?
    Firoozi F
    Curr Urol Rep; 2011 Oct; 12(5):323-6. PubMed ID: 21706178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication: "UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse".
    Murphy M; Holzberg A; van Raalte H; Kohli N; Goldman HB; Lucente V;
    Int Urogynecol J; 2012 Jan; 23(1):5-9. PubMed ID: 22086260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.